APA način citiranja

Brown, J. R., Harb, W. A., Hill, B. T., Gabrilove, J., Sharman, J. P., Schreeder, M. T., . . . Kipps, T. J. (2016). Phase I study of single-agent CC-292, a highly selective Bruton’s tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia. Haematologica.

Čikaški stil citiranja

Brown, Jennifer R., et al. "Phase I Study of Single-agent CC-292, a Highly Selective Bruton’s Tyrosine Kinase Inhibitor, in Relapsed/refractory Chronic Lymphocytic Leukemia." Haematologica 2016.

MLA način citiranja

Brown, Jennifer R., et al. "Phase I Study of Single-agent CC-292, a Highly Selective Bruton’s Tyrosine Kinase Inhibitor, in Relapsed/refractory Chronic Lymphocytic Leukemia." Haematologica 2016.